374 related articles for article (PubMed ID: 34992504)
41. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
42. Correlation of Hematological Parameters With Clinical Outcomes in Cervical Cancer Patients Treated With Radical Radio(chemo)therapy: A Retrospective Study.
Kumar A; Gurram L; Naga Ch P; Nayak P; Mulye G; Chopra S; Engineer R; Shrivastava SK; Gupta S; Ghosh J; Gulia S; Agarwal JP; Mahantshetty U
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):182-191. PubMed ID: 37506980
[TBL] [Abstract][Full Text] [Related]
43. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.
Holub K; Biete A
Clin Transl Oncol; 2019 Jul; 21(7):836-844. PubMed ID: 30470994
[TBL] [Abstract][Full Text] [Related]
44. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
[TBL] [Abstract][Full Text] [Related]
45. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Ma JY; Ke LC; Liu Q
Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
[TBL] [Abstract][Full Text] [Related]
46. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
[TBL] [Abstract][Full Text] [Related]
47. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
48. Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China.
Xu X; Feng T; Li D; Lou H; Lan H
BMC Infect Dis; 2022 Dec; 22(1):941. PubMed ID: 36522614
[TBL] [Abstract][Full Text] [Related]
49. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of responsiveness of neoadjuvant chemotherapy before surgery for patients with stage IB(2)/IIA(2) cervical cancer.
Li R; Lu ST; Si JG; Liu B; Wang H; Mei YY; Linghu H
Gynecol Oncol; 2013 Mar; 128(3):524-9. PubMed ID: 23146686
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Gallee MP; Hart AA; Müller M; Trimbos JB; Helmerhorst TJ
Cancer; 1994 Oct; 74(8):2307-13. PubMed ID: 7922982
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
54. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.
Lau YM; Cheung TH; Yeo W; Mo F; Yu MY; Lee KM; Ho WC; Yeung AC; Law PT; Chan PK
PLoS One; 2015; 10(4):e0122557. PubMed ID: 25855986
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis.
Li D; Huang S; Liu K; Qin Y; Zhang Y; Yang Y
Int J Gynecol Cancer; 2022 May; 32(5):599-605. PubMed ID: 35331994
[TBL] [Abstract][Full Text] [Related]
56. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
[TBL] [Abstract][Full Text] [Related]
57. Predicting the Prognosis of Gastric Cancer by Albumin/Globulin Ratio and the Prognostic Nutritional Index.
Zhang Y; Zhu JY; Zhou LN; Tang M; Chen MB; Tao M
Nutr Cancer; 2020; 72(4):635-644. PubMed ID: 31423840
[No Abstract] [Full Text] [Related]
58. Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.
Deng T; Feng Y; Zheng J; Huang Q; Liu J
J Gynecol Oncol; 2015 Apr; 26(2):111-7. PubMed ID: 25872892
[TBL] [Abstract][Full Text] [Related]
59. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
60. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients.
Zheng L; Zou K; Yang C; Chen F; Guo T; Xiong B
Clin Transl Oncol; 2017 Sep; 19(9):1125-1132. PubMed ID: 28315180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
